Christopher Accettella

This profile gathers the share dealings of Christopher Accettella across 12 companies, led by BlackRock Health Sciences Term Trust, BlackRock Energy & Resources Trust and BlackRock Enhanced Equity Dividend Trust. The record holds 58 filings, for trades running from 31 January 2022 to 31 January 2025.

The open-market record is one-sided, with 4 purchases worth €60k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 42 option exercises.

A typical purchase (the median) is worth €11k. Clusters matter here: 1 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 4 February 2025: a transaction of €2,701, in BlackRock Technology & Private Equity Term Trust. The last insider purchase was made public on 4 October 2024, 744 days ago. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.